Epidemiology and treatment of post-stroke depression.

Neuropsychiatric Disease and Treatment
S Paolucci

Abstract

Mood depression is a common and serious complication after stroke. According to epidemiological studies, nearly 30% of stroke patients develop depression, either in the early or in the late stages after stroke. Although depression may affect functional recovery and quality of life after stroke, such condition is often ignored. In fact, only a minority of patients is diagnosed and even fewer are treated in the common clinical practice. Moreover, the real benefits of antidepressant (AD) therapy in post-stroke depression have not been fully clarified. In fact, controlled studies on the effectiveness of ADs in post stroke depression (PSD) are relatively few. Today, data available suggest that ADs may be generally effective in improving mood, but guidelines for the optimal treatment and its length are still lacking.

Citations

Dec 14, 2011·International Journal of Stroke : Official Journal of the International Stroke Society·Charles EllisLeonard E Egede
Nov 12, 2013·International Journal of Stroke : Official Journal of the International Stroke Society·Leeanne M CareyUNKNOWN START Research Team
May 6, 2016·Stroke; a Journal of Cerebral Circulation·Carolee J WinsteinUNKNOWN American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and
Jan 25, 2019·The Clinical Neuropsychologist·N Beckett Shea-ShumskyJim Grigsby
Aug 7, 2019·Journal of Neuroscience Research·Eric Zhang, Ping Liao
Jan 1, 2011·Aphasiology·Dalia Cahana-AmitayMallory Finley
Nov 15, 2013·BMC Neurology·Shan-Yun ChiuTzung-Yi Tsai
Apr 18, 2015·Molecular Brain·Juhyun SongJong Eun Lee
Jul 22, 2015·The Journal of Nutrition, Health & Aging·A Lewin-RichterK Werheid
Dec 3, 2015·Stroke; a Journal of Cerebral Circulation·Kezhen FeiCarol R Horowitz
Oct 13, 2017·Health Expectations : an International Journal of Public Participation in Health Care and Health Policy·Nicola A CunninghamKaren Methven
Dec 2, 2017·Neurorehabilitation and Neural Repair·Bettina MohrFriedemann Pulvermüller
Mar 28, 2018·International Journal of Environmental Research and Public Health·Liye ZouHuiru Wang
Apr 21, 2018·International Journal of Stroke : Official Journal of the International Stroke Society·Altaf SaadiFarrah J Mateen
Mar 30, 2018·Neurology·Mary G George, Xingquan Zhao
Oct 17, 2013·Archives of Pharmacal Research·Hyun-Jung KimSun-Young Kong
Mar 8, 2013·Journal of Clinical and Experimental Neuropsychology·Gianna CocchiniNicoletta Beschin
Jun 27, 2013·Neuropsychological Rehabilitation·Jacqueline S Laures-Gore, Lauren C Defife
Aug 15, 2014·Journal of Neurology·Maria WostrackYu-Mi Ryang
Dec 11, 2014·Drugs & Aging·Maurizio PompiliPaolo Girardi
Jul 17, 2018·PM & R : the Journal of Injury, Function, and Rehabilitation·Elizabeth E SitaDebjani Mukherjee
May 10, 2020·Health and Quality of Life Outcomes·Pramudika Nirmani KariyawasamDon Chandana Hewage
Nov 16, 2011·Journal of Clinical Nursing·Chophaka Suttipong, Siriorn Sindhu

❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapy
cognitive behavioral therapy

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
Katherine L SalterRobert W Teasell
© 2022 Meta ULC. All rights reserved